// App-Quantinova.ai

1419 : High Prevalence of Relapse in Australian Children with Ph-like Acute Lymphoblastic Leukemia Despite Risk Adapted Treatment

Researchers

Presenter

  • Susan L Heatley

Principal Investigators

  • Teresa Sadras

  • Eva Nievergall

  • Tamas Revesz

  • Michael P Osborn

  • Chris Fraser

  • Chung Hoow Kok

  • Phuong Dang

  • Kelly Quek

  • Nicola C Venn

  • Sarah Moore

  • Tamara Law

  • Anthea Ng

  • Murray D Norris

Medical Centers

  • Centre for Vascular Research, University of New South Wales, Sydney, Australia

  • Childrens Health Queensland, Lady Cilento Childrens Hospital, Brisbane, Australia

  • School of Medicine, University of Adelaide, Adelaide, Australia

  • School of Womens and Childrens Health, University of New South Wales, Sydney, Australia

  • Molecular Diagnostics, Childrens Cancer Institute Australia, Sydney, Australia

  • Department of Haematology - SA Pathology, Adelaide, Australia

  • Cancer Theme, South Australian Health & Medical Research Institute (SAHMRI), Adelaide, Australia

  • Childrens Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, Australia

  • Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, Australia

  • Department of Haematology & Oncology, Womens & Childrens Hospital, Adelaide, Australia

  • Australian and New Zealand Children's Haematology/Oncology Group, Brisbane, Australia

  • The Children's Hospital at Westmead, Westmead, Australia

  • Kids Cancer Centre, Sydney Childrens Hospital, Randwick, Australia

  • Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN

Locations

  • United States

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • B-cell acute lymphoblastic leukemia

Biomarkers

  • Histone-lysine N-methyltransferase 2A

  • T-cell receptor

Drug/Treatment

  • Methotrexate

  • Prednisolone

  • L-Tyrosine

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final